Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0000921895-25-002765

10% owner sold 4,787,331 shares at $17.75 ($84,975,125)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Pontifax Management 4 G.P. (2015) Ltd. 10% owner 2025-10-15 Sale −2,284,612 $17.75 $40,551,863 0 I
Pontifax Management 4 G.P. (2015) Ltd. 10% owner 2025-10-15 Sale −1,121,045 $17.75 $19,898,549 0 I
Pontifax Management 4 G.P. (2015) Ltd. 10% owner 2025-10-15 Sale −1,226,412 $17.75 $21,768,813 0 I
Pontifax Management 4 G.P. (2015) Ltd. 10% owner 2025-10-15 Sale −155,262 $17.75 $2,755,901 0 I
Open-market sales · 4,787,331 sh · avg $17.75 · $84,975,125
Loading xslF345X05/form414601002_10172025.xml…